Ublituxima shows promising results in the new Multiple Sclerosis treatment trials
Editor An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a…
An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a…
